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LETTERS TO THE EDITOR
Nuclear factors,
hs1,2 enhancer and
IgA nephropathy
To the Editor: Within the immunoglobulin H (IgH)
locus, a minisatellite region of 53 bp is duplicated in one
allele of the hs1,2 enhancer lying beside the 1 gene that
encodes IgA1 [1]. In IgA nephropathy patients, this allele
is associated with a severe evolution leading to renal fail-
ure [2, 3]. This duplication increases the transcriptional
strength of the 1 hs1,2 enhancer and results in a higher
rate of IgA1 production in patients, thus likely yielding
heavier IgA1 kidney deposits. Using electrophoretic mo-
bility shift assay, we have found that this minisatellite
region carries potential transcription factor-binding site
(Fig. 1). Despite that it exhibits putative nuclear factor-
kappa B (NF-B)-, Sp-1-, NF-1- and AP-1-like-binding
sites [1], antibody supershift experiments did not show
the involvement of P50, P52, P65, rel-b, c-rel, c-fos, c-jun,
NF-1 and AP-1 nuclear factors (data not shown). Thus,
still unknown nuclear factors bind to the minisatellite re-
gion of the hs1,2 enhancer and might boost the transcrip-
tion of the 1 gene. Their further identification might be
Fig. 1. The minisatellite region in the hs1,2 enhancer had several DNAof interest to improve our knowledge in the course of
binding sites. Nuclear extracts (10 g) were prepared from RPMI and
evolution of IgA nephropathy toward renal failure. U266 (myeloma cell lines) and IM9 and JI cells (B cell lines). Reactions
were analyzed on a 6% polyacrylamide gel. Control line contained P32-
probe alone. Complexes (C) formed between nuclear extract proteinsBarbara Bessette, Laurence Guglielmi, Michel Cogne´,
and labeled probe are indicated with arrows.and Yves Denizot
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